Health of the Nation Presented in 40th Annual CDC Report

Share this content:
Health of the Nation Presented in 40th Annual CDC Report
Health of the Nation Presented in 40th Annual CDC Report

THURSDAY, June 29, 2017 (HealthDay News) -- The health of the United States is summarized in the 40th annual report published by the U.S. Centers for Disease Control and Prevention.

Thomas E. Price, M.D., from the U.S. Department of Health and Human Services, and colleagues explored the health of the nation and summarized trends for the last 40 years.

The highlights of the report included an increase in life expectancy between 1975 and 2015 for the total population; life expectancy declined by 0.1 years for the total population between 2014 and 2015. From 1975 to 2015, there was a decrease in the infant mortality rate from 16.07 to 5.90 per 1,000 live births. During the same period, there was a 61 percent decrease in the age-adjusted heart disease rate from 431.2 to 168.5 deaths per 100,000 population and a 21 percent decrease in the age-adjusted cancer death rate from 200.1 to 158.5 per 100,000 population. Heart disease and cancer remain the top causes of death.

Other findings included a 36.9 percent decrease in the age-adjusted prevalence of current cigarette smoking, an increase in the age-adjusted percentage of adults with obesity (from 1988-1994 to 2013-2014), and an increase in prescription drug use for all age groups (from 1988-1994 to 2013-2014).

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths